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Abstract
Background: Regulated proteolysis by the proteasome is crucial
for a broad array of cellular processes, from control of the cell
cycle to production of antigens.
Results : The rules governing the N-terminal primary and
extended substrate specificity of the human 20S proteasome in
the presence or absence of 11S proteasome activators (REGK/L
and REGQ) have been elaborated using activity-based proteomic
library tools.
Conclusions: The 11S proteasome activators are shown to be
important for both increasing the activity of the 20S proteasome
and for altering its cleavage pattern and substrate specificity.
These data also establish that the extended substrate specificity is
an important factor for proteasomal cleavage. The specificities
observed have features in common with major histocompatibility
complex (MHC) class I ligands and can be used to improve the
prediction of MHC class I restricted cytotoxic T-cell respon-
ses. ß 2001 Elsevier Science Ltd. All rights reserved.
Keywords: Proteasome; Substrate speci¢city; Combinatorial
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1. Introduction
The 20S proteasome is an intracellular protease found
in almost all living cells from prokaryotes to eukaryotes
and is responsible for the majority of cytosolic and nuclear
protein degradation [1,2]. The enzyme forms the proteo-
lytic core of the larger ATP-dependent 26S proteasome
that is essential for maintaining the integrity of the cell
by degrading abnormal proteins and short-lived proteins
that are involved in the regulation of cell cycle, gene tran-
scription, and metabolism. A specialized function of the
proteasome in mammals is the production of epitopes for
presentation on the major histocompatibility complex
(MHC) class I molecules. The cleavage speci¢city of pro-
teasomes is believed to be an important factor in antigen
presentation because MHC class I epitopes must conform
to stringent structural requirements of both length and
composition for e⁄cient presentation.
The 20S proteasome consists of four heptameric rings
stacked upon one another to form a cylindrical particle.
Two inner L-rings contain catalytic subunits whose active
sites face a central proteolytic chamber and two £anking
K-rings that separate the proteolytic chamber from the
external solvent. Early examination of the 20S proteasome
substrate speci¢city suggested that it contained multiple
distinct activities [3]. Several mutational, biochemical and
structural studies on the yeast enzyme led to the conclu-
sion that three of the seven L-subunits in eukaryotic pro-
teasomes harbor proteolytic activity [4^6]. The L1-subunit
(PGPH or Y) is associated with cleavage after acidic ami-
no acids and the L2-subunit (trypsin-like or Z) is associ-
ated with cleavage after basic amino acids, and the L5-sub-
unit (chymotrypsin-like or X) is associated with cleavage
after hydrophobic amino acids. Additional activities for
cleavage after branched-chain amino acids (BrAAP) and
small neutral amino acids have also been reported but
whether these activities are due to additional active sub-
units remains controversial [7].
The 20S proteolytic core can exist in several forms de-
pending on its association with cap complexes. Associa-
tion with the 19S cap (PA700) yields the 26S proteasome,
a complex responsible for ubiquitin-mediated degradation
of proteins [8]. Association with the interferon Q (IFNQ)-
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inducible REGK/L cap (11S or PA28) increases hydrolysis
of most peptides indicating an activation of all three cata-
lytic L-subunits [9]. Association of the proteasome with
another 11S regulatory cap, REGQ [10], causes selective
activation of the trypsin-like(Z) subunit to yield a protea-
some complex with enhanced activity to cleave after basic
amino acids. In addition, asymmetrical hybrid protea-
somes have been identi¢ed that consist of one REGK/L
cap and one 19S cap [11]. The importance of the 20S
proteasome and REGK/L in generating the C-termini of
some MHC class I ligands has been demonstrated [9,12^
14].
De¢ning the substrate speci¢city of the proteasome is
necessary for understanding its role in CTL epitope gen-
eration and other degradation functions. Through the use
of peptide and selected protein substrates, several groups
have studied the cleavage speci¢city of the 20S proteasome
[5,15^17]. However, the guiding principles of proteasome
cleavage speci¢city are still largely unknown because
methods to e⁄ciently sample large numbers of substrates
have been lacking. Recently collections of covalent inhib-
itors were designed to evaluate the speci¢city of the pro-
teasome [18]. The approach provided some important in-
formation on the extended substrate speci¢city of
proteasome subunits and produced a subunit selective in-
hibitor, however, their studies do not necessarily depict a
complete picture of substrate speci¢city since the com-
pounds employed all contained asparagine at the P1-posi-
tion. Furthermore, irreversible inhibitors provide informa-
tion on the initial steps of peptide bond hydrolysis,
substrate binding and acylation, but they do not take
into account subsequent essential steps, deacylation and
product release. Indeed, the lack of a correlation between
covalent modi¢cation by peptide vinyl sulfones and sub-
strate hydrolysis has been recently demonstrated [19]. De-
¢ning the primary and extended speci¢city of the 20S pro-
teasome in the presence or absence of various activators
will increase our understanding of proteasomal activity,
provide tools for probing function through the design of
substrates and inhibitors, and will aid in the prediction
of epitope production and destruction. Here we describe
in detail, the P4, P3, P2 and P1 substrate speci¢city of
the human 20S proteasome and proteasome^REG com-
plexes.
2. Results and discussion
To reveal the N-terminal P1 to P4 substrate speci¢city
of the human 20S proteasome and its 11S REG com-
plexes, exhaustive peptide library con¢gurations of the
P4^P1 sites were synthesized containing the C-terminal
£uorogenic leaving group 7-amino-4-carbamoylmethylcou-
marin (acc) (Fig. 1A) [20]. Proteolytic release of the cou-
marin leaving group results in increased £uorescence and
allows for the sensitive and continuous determination of
cleavage rates. The substrates were synthesized in two po-
sitional scanning formats and provide the facile determi-
nation of a protease’s P4^P1 substrate speci¢city. In the
¢rst format, the ‘one-position ¢xed’ library, the substrates
are pooled in four sets of 19 sublibraries (76 wells of 6859
substrates/well) where in each sublibrary one position in
the tetrapeptide is known and the other three positions
contain an equimolar mixture of the 19 amino acids (cys-
teine is excluded and methionine is replaced with the iso-
steric amino acid, norleucine). In the second library, the
‘two-position ¢xed’ library, the format is more complex in
that two positions in the tetrapeptide are known and the
other two positions contain an equimolar mixture of the
19 amino acids (2166 wells of 361 substrates/well). Screen-
ing of the one-position ¢xed library allows for a gross
overview of the substrate speci¢city of the proteasome at
each site, while screening of the two-position ¢xed library
allows for a more detailed dissection of the dependencies
between sites.
The substrate cleavage preferences of the 20S protea-
some are dramatically altered depending on the 11S
REG present (Fig. 1B). While activity from all three sub-
units is present in the 20S proteasome, the major activity is
cleavage after the P1-aliphatic amino acids leucine and
alanine with an absence of cleavage after P1-proline
(Fig. 1B). Cleavage after aliphatic amino acids constitutes
Fig. 1. (A) Structure of £uorogenic peptide libraries. (B) Results from the one-position ¢xed positional scanning library where the y-axis represents the
rate of substrate cleavage (in relative £uorescence units) over time per nanomolar of 20S proteasome (RFU/s/nM) and the x-axis represents the P1-ami-
no acid. The three non-¢xed positions contain an equimolar mixture of 19 amino acids (Cys and Met excluded, Nle included and indicated with ‘n’) for
a total of 6859 substrates/well. (C) Ratio of the activity of the 11S proteasome activator (REGK/L and REGQ) complexes over the activity of the un-
complexed 20S in the P1-library (changes in P1-Gly and P1-Pro are not shown due to minimal activity of the uncomplexed 20S toward these amino
acids). Data from these ¢gures show that the 11S proteasome activators (REGK/L and REGQ) selectively enhance speci¢c proteasomal cleavage.
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Fig. 1 (Continued).
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Fig. 2. Results from the two-position ¢xed libraries where the shade of the square represents the rate of substrate cleavage (in relative £uorescence
units) over time per nanomolar of 20S proteasome (RFU/s/nM) and the x- and y-axes represent the positions P1-, P2-, P3- or P4-amino acid. The two
positions in the substrate that are not held constant contain an equimolar mixture of 19 amino acids (Cys and Met excluded, Nle included and indi-
cated with ‘n’) for a total of 361 substrates/well. (A) 20S proteasome alone, (B) 20S proteasome plus PAK/L, (C) 20S proteasome plus PAQ, (D) 20S
proteasome plus PAK/L and 5 WM lactacystin.
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Fig. 2 (Continued).
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the major activity in all forms of the proteasomes tested,
however, in the case of REGK/L there is an additional
increase in cleavage after basic, acidic, polar and aromatic
amino acids (Fig. 1C). A more narrow proteasome activa-
tion pro¢le is observed in the presence of REGQ (Fig. 1B).
The selective activation for cleavage after basic amino
acids by the REGQ complexed proteasome was expected
from previously published results [10], however a dramatic
increase in cleavage after tryptophan residues was also
observed (Fig. 1C).
Extended substrate speci¢city of the proteasome and its
complexes is also revealed from the activity pro¢les. The
P2-substrate speci¢city pro¢le is similar for all complexes,
however, the pro¢les from the P3 and P4 positions show
striking di¡erences between the proteasome complexes;
broad for REGK/L and biased towards basic amino acids
for the REGQ complex. The preference for basic amino
acids in the primary and extended cleavage sites by the
REGQ complex may re£ect its localization to the nucleus
[21] and its potential role in degrading nuclear proteins
that have a higher composition of basic amino acids
[22]. An additional intriguing di¡erence between the two
Fig. 3. Histograms of the two-position ¢xed library showing the extended substrate speci¢city when the P1-position is held constant as (A) arginine,
(B) aspartate, (C) phenylalanine and (D) leucine. The x-axis represents a ¢xed amino acid and the y-axis represents the rate of substrate cleavage (in
relative £uorescence units) over time per nanomolar of 20S proteasome (RFU/s/nM).
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complexes is seen in the selectivity for tryptophan. While
the REGK/L complex disfavors tryptophans in the primary
and extended sites, the REGQ complex favors tryptophan
in these positions. Another obvious proteasomal sequence
preference uncovered from these pro¢les is the presence or
absence of proline at the primary and extended sites. Pro-
line at the P1 and P2 positions is not tolerated for all
forms of the proteasome tested. Proline is accepted at
the P3 position and is the most favored amino acid in
the P4 position for the two REG^proteasome complexes.
Proline is postulated to be an important factor in the
e⁄cient production of class I epitopes through the preven-
tion of proteasomal cleavage within the epitope [23]. With
the majority of proteasomal products yielding sequence
lengths smaller than the 8^9 amino acids, as required for
class I presentation [24], protection of epitopes from inter-
nal cleavage is an important issue to address.
A comprehensive and exhaustive view of all interdepen-
dencies for the P4 to P1 diversity space was assessed em-
ploying the two-position ¢xed library (Fig. 2). The result-
ing activity pro¢les mirror those seen in the one-position
¢xed library: the activity of the 20S proteasome clusters in
the hydrophobic regions of the pro¢les ; the activity of the
REGK/L^proteasome complex broadens at all substrate
Fig. 3 (Continued).
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positions; the activity of the REGQ^proteasome complex
also broadens but clusters in the basic region of the pro-
¢les.
While each of the three active L-subunits displays sub-
strate speci¢city determinants that distinguish it from the
others, the L1 (or PGPH)-subunit, with preference for
cleavage after acidic amino acids, displays the most restric-
tive extended substrate speci¢city (Figs. 2 and 3A). In the
presence of REGK/L or REGQ the L1-subunit displays a
preference for aromatic or large aliphatic amino acids at
the P2-position, proline, alanine or large aliphatic amino
acids at the P3-position and broad selectivity at the P4-po-
sition (Fig. 3A).
The L2 (or trypsin-like)-subunit displays the greatest
di¡erence between the REGK/L and REGQ proteasome
complexes (Figs. 2 and 3B). In the presence of REGQ,
the L2-subunit’s preference for cleavage after basic amino
acids expands to the extended binding sites, with a striking
preference for basic amino acids in the P2 and P3 posi-
tions. In the presence of REGK/L the L2-subunit’s prefer-
ence for basic amino acids at P3 is retained; however, the
bias for basic amino acids in P2 and P4 is signi¢cantly
diminished in comparison to REGQ. Further di¡erences
between the L2-subunit of the REGK/L and REGQ protea-
some complexes are manifested in what amino acids are
not acceptable at the extended positions. REG-associated
proteasomes do not accept proline, aspartic acid or tryp-
tophan at P2, and tryptophan is disfavored at the P3 and
P4 sites for the L2-subunit. This is in stark contrast to the
extended speci¢city of the L2-subunit in the REG Q-com-
plexed proteasome that has signi¢cant, if not preferential,
activity for tryptophan in the P3 and P4 positions of the
substrate sequence. Unlike the preference for proline in
the P3 position of the L1-subunit, the L2-subunit disfavors
proline in this position. Moreover, aspartic acid is disfa-
vored at each of the extended sites of the L2-subunit for all
forms of the 20S proteasome tested.
Cleavage after the aromatic amino acids is increased for
REGQ-proteasomes while remaining approximately the
same or somewhat lower for cleavage after aliphatic amino
acids (Fig. 1). In contrast, the REGK/L-proteasome shows
increased cleavage after aliphatic amino acids and the ar-
omatic amino acids, tyrosine and phenylalanine, but not
tryptophan. The extended substrate speci¢city pro¢le has
similar features for all forms of the 20S proteasome when
P1 is held constant as phenylalanine (Figs. 2 and 3C).
These features include preference of glycine and absence
of proline at P2 and preference for phenylalanine at P4.
Fig. 4. Histogram relating the frequency of amino acids at the C-termini of 5640 MHC class I epitopes (gray bars) from the MHCPEP database [30] to
the activity of the 20S proteasome-PAK/L complex in the one-position ¢xed library (black bars).
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One notable di¡erence with the REGQ complex is an in-
crease in basic amino acids at the extended sites.
Substrate preferences in the extended sites for cleavage
after P1 aliphatic amino acids are extremely broad for all
forms of the proteasome. The P2 site displays the most
selectivity with a lack of large bulky amino acids at this
position, in addition to the pervasive absence of proline
(Figs. 2 and 3C). The acceptability of most amino acids in
the extended sites may account for the large rates of cleav-
age after aliphatic amino acids seen in the libraries. A
possible reason for the seemingly broad sequence-inde-
pendent activity is that several subunits cleave after ali-
phatic amino acids, a property that has been qualitatively
demonstrated with active site mutants of the yeast 20S
proteasome [15]. Screening the substrate library with the
REGK/L complex in the presence of the L5-speci¢c pro-
teasome inhibitor lactacystin [25], resulted in abolition of
most of the cleavage after hydrophobic and aliphatic ami-
no acids (Fig. 2D). Examination clearly shows that the
extended substrate pro¢le for P1-Leu now approximates
that of P1-Asp, indicating that both the L1- and L5-sub-
units cleave after aliphatic amino acids. This is consistent
with the observation by Cardozo et al. that a proline res-
idue at P3 directs substrates to the BrAAP activity of the
proteasome [26].
Several studies suggest that catalytic activation of the
20S proteasome by 11S activators is achieved by opening
a pore through the K-rings. The recent structure of the
yeast 20S proteasome and the REGK homolog from Try-
panosoma brucei (PA26) shows that upon complex forma-
tion, conformational changes occurring in the K-subunits
result in a dramatic increase in pore size [27]. While the
substrate pro¢les generally support this model, the model
does not completely account for the selective changes in
primary and extended substrate speci¢city observed in the
results presented here. One must propose that binding of
REGs to the proteasome results in both increased sub-
strate access to the central proteolytic chamber and altered
conformations in the substrate binding pockets of the cat-
alytically active L-subunits.
Subunit-speci¢c substrate sequences often translate into
selective inhibitors, but not as a rule. By examining the
substrate preferences observed for the L1-, L2-, and L5-
subunits, we designed four peptide aldehyde inhibitors.
C-terminal aldehydes are capable of forming a stable
hemi-acetal with the hydroxyl of the nucleophilic N-termi-
nal threonine residue. As predicted, the aldehyde inhibitor
designed against the L1-subunit Ac-Glu-Pro-Phe-Asp-H
selectively inhibited the cleavage of substrates designed
to monitor the L1-subunit activity, all with a similar Ki
of approximately 40 nM (Table 1). These data further
demonstrate that the extended substrate speci¢city is an
important determinant in the partitioning of tetrapeptides
with aliphatic amino acids at P1 to speci¢c active sites.
While both Ac-Glu-Pro-Phe-Leu-acc and Ac-His-His-Ser-
Leu-acc contain leucine at P1, only the former substrate
with the L1-like extended sequence is inhibited by Ac-Glu-
Pro-Phe-Asp-H. Even at a concentration of 50 WM this
peptide aldehyde inhibited less than 20% of the hydrolysis
of substrate designed to monitor the other subunits. The
peptide aldehyde inhibitor designed against the L2-sub-
unit, Ac-Pro-Arg-Gln-Arg-H, inhibits only the substrate
used to monitor L2 activity, Ac-Nle-Arg-Nle-Arg-acc
with a Ki of 210 nM (Table 1). The aldehyde inhibitors
designed against the optimal substrate speci¢city of the
L5-subunit, Ac-Pro-Glu-Gly-Phe-H and Ac-His-His-Ser-
Leu-H were not very potent inhibitors, with Kis of approx-
imately 30 WM and 800 nM, respectively (Table 1). This is
in contrast to the very tight inhibition (KiV1 nM) ob-
served with carbobenzoxy-Leu-Leu-Leu-H (MG-132).
This result is consistent with the observation by Dick et
al. [28] that the L5-subunit is prone to substrate inhibition
by a substrate that contains large bulky P2-amino acid,
whereas, substrate inhibition is not observed with sub-
strates that contain small or polar amino acids in the
P2-position (data not shown). Caution must be exercized
when drawing conclusions about the substrate speci¢city
of an enzyme through the use of inhibitors since the same
features that produce an e⁄ciently hydrolyzed substrate
will not necessarily produce a potent inhibitor.
One of the initial steps in antigen processing is the deg-
radation of a protein by the proteasome. The generated
peptide fragments are then transported to the endoplasmic
reticulum by the transporter associated with antigen pro-
cessing (TAP) where they are loaded onto MHC class I
molecules for surface display. Peptides with C-terminal
hydrophobic and charged amino acids are preferences
shared by the proteasome, TAP [29] and MHC class I
Table 1
Aldehyde inhibitor kinetics (20S+K/L)
Substrate Ac-EPFD-al Ki (nM) Ac-PRQR-al Ki (nM) Ac-PEGF-al Ki (nM) Ac-HHSL-al Ki (nM) Z-LLL-al Ki (nM)
Ac-nRnR-ACC NIa 210 þ 30 NI NI 1900 þ 570
Ac-EPFD-ACC 40 þ 4 NI NI NI 860 þ 170
Ac-EPFE-ACC 32 þ 11 NI NI 11 800 þ 3900 49 þ 15
Ac-EPFL-ACC 45 þ 10 NI NI 6730 þ 2900 400 þ 60
Ac-PEGF-ACC NI NI 38 700 þ 4700 840 þ 130 1.0 þ 0.2
Ac-HHSL-ACC NI NI 31 400 þ 5200 720 þ 90 0.7 þ 0.1
Ac-VRGW-ACC NI NI NI 8462 þ 5200 2.4 þ 1.3
aNI = no inhibition (less than 20% inhibition observed at 50 WM inhibitor).
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molecules. The power of the pro¢ling method presented
here is that all possible non-prime tetrapeptide sequences
are simultaneously and continuously monitored. Because
the proteasome functions in generating the C-termini of
MHC class I epitopes, knowledge of not only the optimal
cleavage sites but also the sub-optimal and disfavored
cleavage sites should permit construction of reliable algo-
rithms to determine what degradation sequences are likely
to be generated from a protein sequence. Indeed, even
though proteasome processing is an early step in antigen
presentation, a correlation exists between the results pre-
sented here and amino acid sequences found in the
C-terminal portions of MHC class I ligands (Fig. 4)
[30,31]. In practical terms, analysis of the proteasome sub-
strate speci¢city data presented here could allow for the
design of more immunogenic antigens in vaccines, namely,
epitopes that not only contain optimal cleavage sites but
also are resistant to internal degradation [32]. Further-
more, the development of the function-based proteomics
tools described in this manuscript allows for monitoring of
the precise changes in substrate speci¢city of proteasomes
from various tissues, cells or even other organisms [33,34].
This is of considerable interest since the L1-, L2-, and L5-
subunits can be replaced by the IFNQ-induced subunits,
lmp2, MECL1, and lmp7. While these IFNQ-induced pro-
teasomal subunits have been postulated to play a role in
the processing of certain antigens, their role is still some-
what controversial [16,35,36]. The proteomics tools pre-
sented here may not only aid in dissecting the function
of speci¢c proteasome populations, but may also aid in
validating them as targets for therapeutic intervention.
3. Signi¢cance
The proteasome plays a crucial function in maintaining
the ¢delity of an organism through the degradation of
abnormal and transient proteins and through the produc-
tion of the epitopes for MHC class I presentation. Exhaus-
tive and complex con¢gurations of £uorogenic substrates
have proven to be useful in de¢ning the N-terminal pri-
mary and extended substrate speci¢city of the human 20S
proteasome in the presence of 11S proteasome activators
(REGK/L and REGQ). The resultant pro¢les enable the
characterization of global proteasome activity and the dis-
section of the individual proteasome subunit activities.
Traditionally, the cleavage preference for the amino acid
N-terminal to the scissile bond (P1) of the substrate has
been relied upon to de¢ne the activity of the proteasome
subunits. However, the pro¢ling data presented here sug-
gests that the extended speci¢city is a critical feature of
substrate hydrolysis. The wealth of information generated
enables the design of more speci¢c substrates and inhibi-
tors for targeting proteasome complexes and de¢nes the
pool of peptides generated from the proteasome for MHC
class I presentation.
4. Materials and methods
4.1. Enzyme and REG preparation
20S proteasome, REGK/L and REGQ preparation: human 20S
proteasome was prepared from outdated blood by previously
described methods [37]. 11S activator caps, REGK/L and
REGQ, were prepared as previously described [10].
4.2. Substrate and inhibitor synthesis
Substrates and substrate libraries were synthesized using meth-
ods described previously [20]. Aldehyde inhibitor Ac-Pro-Arg-
Gln-Arg-H was prepared using semicarbazone methodology
[38]. Inhibitors, Ac-Glu-Pro-Phe-Asp-H, Ac-Pro-Glu-Gly-Phe-
H, and Ac-His-His-Ser-Leu-H, were prepared using Weinreb
amide methodology [39].
4.3. Substrate library kinetic screening
Puri¢ed 20S proteasome (25 nM for assays without REG, 1 nM
for assays with 70 nM REGK/L, and 10 nM for assays with 700
nM REGQ) in a bu¡er containing 60 mM Tris pH 7.5, 10 mM
KCl, and 5 mM MgCl2, was pre-incubated at 37‡C for 10 min to
allow for association of 20S with REG caps. The pre-incubated
proteasome was then added to the substrate libraries and £uores-
cence was monitored for 30 min at Vex of 380 nm and Vem of 450
nm in a Molecular Devices Gemini XS microtiter plate reader.
Inhibitors were assayed in the same manner with pre-incubation
of 1 nM 20S proteasome, 70 nM REGK/L and 4UKi concentra-
tion of inhibitor.
4.4. Inhibitor analysis
Multiple concentrations of inhibitors (0.0001 mM to 50 WM)
were pre-incubated at 37‡C for 10 min with 20S proteasome and
REGK/L. The inhibited proteasome was then added to 5 WM of
puri¢ed substrate and the Ki was determined using the Henderson
equation for tight-binding inhibitors (Table 1).
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